Dave Watson is the Founder & CEO of Resero Analytics, where Dave focuses on automating reporting with TurboToxicology to clear backlogs. Prior to founding Resero Analytics, Dave spent 19 years at Eli Lilly and Company as a Senior Research Advisor in drug discovery and development for various disease areas. Dave also has experience as a Post-Doc at NIEHS and a PhD student at Duke University in Pharmacology and Toxicology. Dave holds a Bachelor of Science in Chemistry from St. Lawrence University and an MBA from MIT Sloan School of Management.
This person is not in any teams